Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.

K Ikekubo1, M Hino, H Ito

  • 1Department of Nuclear Medicine and Medicine, Kobe City General Hospital, Japan.

Annals of Nuclear Medicine
|July 1, 1990
PubMed
Summary

Thyrotoxic Graves' disease can present with normal thyroidal uptake of technetium-99m pertechnetate (99mTc). Early identification of these patients is crucial for effective treatment and improved prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiographic A-V Shunt during Interventional Thrombolysis for Acute Cerebral Embolism. A New Predictive Sign for Hemorrhagic Complication.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2010
Same author

Multiplex real-time PCR for exhaustive detection of diarrhoeagenic Escherichia coli.

Journal of applied microbiology·2009
Same author

Histamine inhibits chemotaxis, phagocytosis, superoxide anion production, and the production of TNFalpha and IL-12 by macrophages via H2-receptors.

International immunopharmacology·2001
Same author

[Lung volume reduction surgery in pulmonary emphysema].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2001
Same author

Helical CT scanning of laryngeal deviation.

Auris, nasus, larynx·2001
Same author

Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.

Thyroid : official journal of the American Thyroid Association·1998

Area of Science:

  • Endocrinology
  • Nuclear Medicine
  • Internal Medicine

Background:

  • Graves' disease is a common cause of hyperthyroidism.
  • Thyroidal uptake of technetium-99m pertechnetate (99mTc) is typically elevated in thyrotoxic Graves' disease.
  • A subset of patients may present with normal 99mTc uptake, posing diagnostic challenges.

Purpose of the Study:

  • To investigate the clinical and laboratory characteristics of thyrotoxic Graves' disease patients with normal 99mTc uptake.
  • To differentiate these patients from other causes of thyrotoxicosis.
  • To assess the diagnostic utility of 99mTc uptake and TBII/TSab measurements.

Main Methods:

  • Retrospective analysis of 201 untreated thyrotoxic Graves' patients over 4 years.
  • Evaluation of thyroid uptake and scintigraphy using 99mTc.

Related Experiment Videos

  • Measurement of thyroid-binding immunoglobulin (TBII) and thyroid-stimulating immunoglobulin (TSab) activity.

    • Main Results:

    • Identified 24 (11.9%) thyrotoxic Graves' patients with normal 99mTc uptake.
    • These patients exhibited normal thyroid uptake with diffuse trapping, smaller goiters, lower hormone levels, and reduced TBII/TSab compared to high-uptake Graves' disease.
    • Normal 99mTc uptake patients were distinct from destruction-induced thyrotoxicosis and autonomous thyroid lesions.

    Conclusions:

    • Thyrotoxic Graves' disease with normal 99mTc uptake is a recognized entity.
    • 99mTc uptake studies and TBII measurement are valuable diagnostic tools.
    • Early identification of these patients may represent an early stage of Graves' disease, benefiting treatment and prognosis.